Northwestern Mutual Wealth Management’s Edesa Biotech EDSA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33	Buy	+4	New	+$36	﹤0.01%	4032

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northwestern Mutual Wealth Management's EDSA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Edesa Biotech (EDSA) in Q2 2026: 4 shares worth $33. The stake represents ﹤0.01% of the portfolio and ranks #4032 among its holdings.

33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

Northwestern Mutual Wealth Management held 4 shares of Edesa Biotech worth $33 as of Q2 2026.
Edesa Biotech was a new Northwestern Mutual Wealth Management position in Q2 2026.
Edesa Biotech made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4032 holding.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.